Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIGH-CAP: Acute and Protracted Effects of High Potency Cannabis
NCT06859723Phase 1Recruiting
- Sponsor
- University of California, Los Angeles
- Start
- Jul 2025
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of dronabinol in pain (3 arms), sponsored by University of California, Los Angeles. Primary endpoints: Subject-rated drug effects of abuse liability at 3 hours and Analgesia as measured using the Cold Pressor Test at 3 hours. Started Jul 2025; status: recruiting.
02
Drugs
dronabinol
03
Conditions
pain
Beyond the preview
Go deeper on NCT06859723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06859723.